Han-Wen Liu

Han-Wen Liu

Auto-generated profile, based on publicly available information

Han-Wen Liu

Division of Endocrine and Metabolism, Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2022 in Nutrition Research
Verified
Journal Article
Closed access
SCShih-Wen Chiang
Shih-Wen Chiang
HLHan-Wen Liu
Han-Wen Liu
ELEl-Wui Loh
El-Wui Loh
KTKa-Wai Tam
Ka-Wai Tam
JWJzy-Yu Wang
Jzy-Yu Wang
YKYi-Chun Kuan
Yi-Chun Kuan

17 May 2023 in Journal of the Formosan Medical Association
Verified
Journal Article
Open access
YYYun-Hsuan Yang
Yun-Hsuan Yang
YCYu-Ling Chang
Yu-Ling Chang
BLBo-Ching Lee
Bo-Ching Lee
CLChing-Chu Lu
Ching-Chu Lu
WWWei-Ting Wang
Wei-Ting Wang
CHChii-Min Hwu
Chii-Min Hwu
Adrenal venous sampling (AVS) is a crucial method for the lateralization of primary aldosteronism (PA). It is advised to halt the use of the patient's antihypertensive medications and correct hypokalemia prior to undergoing AVS. Hospitals equipped to conduct AVS should establish their own diagnostic criteria based on current guidelines. If the patient's antihypertensive medications cannot be discontinued, AVS can be performed as long as the serum renin level is suppressed. The Task Force of Taiwan PA recommends using a combination of adrenocorticotropic hormone stimulation, quick cortisol assay, and C-arm cone-beam computed tomography to maximize the success of AVS and minimize errors by using the simultaneous sampling technique. If AVS is not successful, an NP-59 (131 I-6-β-iodomethyl-19-norcholesterol) scan can be used as an alternative method to lateralize PA. We depicted the details of the lateralization procedures (mainly AVS, and alternatively NP-59) and their tips and tricks for confirmed PA patients who would consider to undergo surgical treatment (unilateral adrenalectomy) if the subtyping shows unilateral disease.

11 May 2023 in Journal of the Formosan Medical Association
Verified
Journal Article
Open access
Chien-Wei HuangChien-Wei Huang
Chien-Wei Huang
KTKun-Hua Tu
Kun-Hua Tu
KFKang-Chih Fan
Kang-Chih Fan
CTCheng-Hsuan Tsai
Cheng-Hsuan Tsai
WWWei-Ting Wang
Wei-Ting Wang
CHChii-Min Hwu
Chii-Min Hwu
Confirmatory tests for diagnosis of primary aldosteronism (PA) play an important role in sparing patients with a false-positive aldosterone-to-renin ratio (ARR) screening test from undergoing invasive subtyping procedures. We recommend that patients with a positive ARR test should undergo at least one confirmatory test to confirm or exclude the diagnosis of PA before directly proceeding to subtype studies, except for patients with significant PA phenotypes, including spontaneous hypokalemia, plasma aldosterone concentration >20 ng/dL plus plasma renin activity below a detectable level. Although a gold standard confirmatory test has not been identified, we recommend that saline infusion test and captopril challenge test, which were widely used in Taiwan. Patients with PA have been reported to have a higher prevalence of concurrent autonomous cortisol secretion (ACS). ACS is a biochemical condition of mild cortisol overproduction from adrenal lesions, but without the typical clinical features of overt Cushing's syndrome. Concurrent ACS may result in incorrect interpretation of adrenal venous sampling (AVS) and may lead to adrenal insufficiency after adrenalectomy. We recommend screening for ACS in patients with PA scheduled for AVS examinations as well as for adrenalectomy. We recommend the 1-mg overnight dexamethasone suppression test as screening method to detect ACS.